Trial · NCT02972918
Preoperative levosimendán and Hip Fracture
NCT02972918, Completed, Hospital Universitario de Canarias
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Preoperative levosimendán and Hip Fracture. Trials, record NCT02972918. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02972918
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Preoperative levosimendán and Hip Fracture
- NCT number
- NCT02972918
- Status
- Completed
- Enrollment
- 19 participants, actual
- Lead sponsor
- Hospital Universitario de Canarias
- Conditions
- Ventricular Dysfunction, Left, Hip Fracture
- Interventions
- Levosimendan
- First posted
- 2016-11-25
- Last updated
- 2020-02-05
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The effects of Levosimendan on left ventricular function. | Baseline and every 24 hours postoperative, 48 h postoperative, and 7 days and after 30 days postoperative. | Changes of left ventricular function as assessed transthoracic. |
| Primary | Change in cardiac index | 48 hours after start of iv infusion | Measured through arterial pulse wave analysis. A baseline measurement is done before infusion is started |
| Secondary | Changes in transport and tissue perfusion of oxygen | 1 to 2 day postoperative | measured by arterial and venous blood gases |
| Secondary | Changes in renal function | 1 to 7 days postoperative | Proportion of subjects who develop AKIN stage 1 (increase \> 0.3 mg/dl or \> 25% in serum creatinine from previous visit) |
| Secondary | Changes in NT-proBNP and troponin I | 24 hours postoperative, 48 h postoperative, 72 h postoperative, and 168 h postoperative | Plasma NT-proBNP levels were measured |
| Secondary | Number of patients with adverse. | 30 days postoperative | Development of arrhythmias |
| Secondary | Number of patients with adverse. | 30 days postoperative | Occurence of nausea/vomiting |
| Secondary | Number of patients with adverse event. | 30 days postoperative | Occurence of headache |
| Secondary | Use of high inotropes (dopamine, Norepinephrine) | after 12 hours, after 48 hours and every 24 hours if still in the PO-Unit | during postoperative unit stay. |
| Secondary | morbidity | 3 months | All cause |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02972918
GET https://conductscience.org/api/trials/v1/NCT02972918/registered